# Cytal® Wound Matrix and MicroMatrix® Wound Study

> **NCT03632954** · — · TERMINATED · sponsor: **Integra LifeSciences Corporation** · enrollment: 37 (actual)

## Conditions studied

- Wounds

## Interventions

- **DEVICE:** ACell Arm

## Key facts

- **NCT ID:** NCT03632954
- **Lead sponsor:** Integra LifeSciences Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2018-12-11
- **Primary completion:** 2020-01-27
- **Final completion:** 2020-01-27
- **Target enrollment:** 37 (ACTUAL)
- **Why stopped:** Sponsor Decision
- **Last updated:** 2021-05-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03632954

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03632954, "Cytal® Wound Matrix and MicroMatrix® Wound Study". Retrieved via AI Analytics 2026-09-04 from https://api.ai-analytics.org/clinical/NCT03632954. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*